Rhythm Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RYTM for the last quarter is 25.97 M USD, and it's 7.15% higher compared to the previous quarter. The net income of Q1 24 is -141.37 M USD.